BRIEF published on 04/30/2024 at 11:05, 1 year 7 months ago New Partnership Between BioMed X Institute and Merck Focuses on Immuno-Oncology Cancer Research BioMed X Institute Immunotherapy Merck Tumor Immunogenicity
PRESS RELEASE published on 04/30/2024 at 11:00, 1 year 7 months ago New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg Biomedical research institute, BioMed X, partners with Merck to develop novel immunotherapeutic strategies to enhance tumor immunogenicity for cancer patients Cancer Research Immunotherapy Merck Tumor Immunogenicity BioMed X
PRESS RELEASE published on 02/06/2024 at 16:00, 1 year 9 months ago New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine BioMed X Institute and Universitatsmedizin Mannheim researchers publish results of collaboration on new neoepitope vaccine in diffuse midline glioma in Science Advances BioMed X Institute Universitatsmedizin Mannheim Neoepitope Vaccine Diffuse Midline Glioma Science Advances
PRESS RELEASE published on 11/07/2023 at 12:00, 2 years ago BioMed X Launches a New Call for Application in Autoimmune Disease Research
PRESS RELEASE published on 10/31/2023 at 17:00, 2 years 1 month ago BioMed X and AbbVie Start New Research Project in the USA
PRESS RELEASE published on 06/29/2023 at 11:00, 2 years 5 months ago BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
PRESS RELEASE published on 04/27/2023 at 14:00, 2 years 7 months ago BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
PRESS RELEASE published on 04/04/2023 at 11:00, 2 years 8 months ago BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Published on 12/05/2025 at 18:45, 8 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 33 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 53 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 38 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 53 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 18:15, 38 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 1 hour 7 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 53 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 17:18, 1 hour 35 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 35 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 42 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 42 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 55 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
